ORNL licenses four cryogenic pellet fueling technologies to Type One Energy to support stellarator fusion development

Oak Ridge National Laboratory and fusion company Type One Energy signed a licensing agreement on August 5 at the Nuclear Opportunities Workshop in Knoxville, Tennessee. The deal covers four cryogenic pellet fueling technologies developed at ORNL—inventions designed to support the fueling systems of next-generation stellarator fusion reactors.

The agreement moves ORNL’s fueling research from the lab into commercial use. It’s also another sign that the partnership between the national lab and the Oak Ridge-based startup is picking up real momentum.

ORNL and Type One Energy sign cryogenic fueling license

The August 5 signing happened at the Nuclear Opportunities Workshop—a fitting venue for a deal that pushes federally developed fusion tech closer to market. The agreement covers four distinct ORNL inventions, each targeting a specific challenge in building and running cryogenic pellet fueling systems for fusion reactors.

Together, the four technologies form what ORNL describes as a novel extrusion system capable of producing pellets at rates appropriate for actual reactor operations.

ORNL Director Stephen Streiffer called it a natural next step. “This license is an exciting next step in our partnership, moving our fueling research out of the lab and into application,” he said. John Canik, Type One Energy’s Chief Science and Engineering Officer, was equally direct: “Fueling the fusion reaction with high repetition and high reliability is one of the most essential technologies for continuous generation of fusion power.”

Type One Energy is based in Oak Ridge, and that proximity to ORNL isn’t a coincidence. It reflects a deliberate strategy of staying close to a lab with decades of fusion research behind it.

Why cryogenic pellet fueling is needed for fusion reactors

Running a fusion reactor isn’t like flipping a switch and walking away. Reactors burning deuterium and tritium must be continuously refueled—ions get consumed in the reaction or escape the magnetic fields containing them, so replacement is an ongoing requirement, not a one-time setup.

Cryogenic pellet fueling is currently the most effective method available. The process forms solid hydrogen pellets at temperatures just a few degrees above absolute zero, then injects them at high speed directly into the plasma. Compared to gas puffing—the other main approach—pellet injection reaches deeper into the plasma core and produces better overall performance.

Tritium complicates everything. Unlike deuterium, which is relatively abundant and manageable, tritium is scarce and radioactive, creating serious containment and reprocessing challenges that standard pellet injectors weren’t built to handle.

There’s also a production rate problem. No existing pellet injectors can generate pellets fast enough for reactor-scale operations—and that gap is exactly what ORNL’s licensed technologies are designed to close.

The four licensed technologies and their functions

The first technology, the Tritium-Compatible Cryogenic Pellet Gas Gun, uses tritium-compatible materials and includes real-time pellet size control. Its simplified, robust design minimizes stress-induced failures—critical for any system expected to run reliably over long periods in a fusion environment.

The second, the Tritium-Compatible Cryogenic Screw Extruder, is built for tritium service and radiation resistance. It maintains hermetic containment during continuous pellet production while handling a wide range of extrusion temperatures, flow rates, cross sections, and isotope mixtures. That flexibility matters when operating conditions shift mid-run.

The third addresses a direct safety concern. The Pressure Relief Device for Cryogenic Fusion Fuels is a reusable valve providing overpressure protection at temperatures below -424 °F (20 kelvin). It can cycle repeatedly through tritium fuel systems—something conventional relief devices simply aren’t designed to do at those extremes.

The fourth, the Solid Conveyance with Single Phase Change Method, tackles the problem of excess extrusion material. Rather than discarding it or routing it through external handling systems, this closed-loop recirculation design converts the excess back into gas for pellet production. The result is a reduced tritium inventory and a more self-contained fueling process—both meaningful advantages for long-term reactor operation.

Together, the four technologies form what ORNL describes as a novel extrusion system capable of producing pellets at rates appropriate for actual reactor operations.

Context: ORNL–Type One Energy collaboration and fusion commercialization

Type One Energy isn’t new to working with ORNL. The company was established in 2019, received venture backing in 2023, and has already collaborated with the lab on a high-heat flux test facility and a joint project under the DOE’s Innovation Network for Fusion Energy—known as INFUSE. This cryogenic fueling license extends a relationship that’s been building for years.

The company’s broader ambition is laid out in its FusionDirect™ program, which targets the lowest-risk, shortest-schedule path to a fusion power plant over the coming decade. It applies advanced manufacturing methods, modern computational physics, and high-field superconducting magnets to its optimized stellarator design.

On the ORNL side, the development team behind these technologies includes Steve Meitner and Dean McGinnis, along with former staff members Larry Baylor and Jeff Ulreich—researchers whose work reflects the lab’s longstanding leadership in fusion fueling science.

Oak Ridge National Laboratory is managed by UT-Battelle for DOE’s Office of Science, the single largest supporter of basic research in the physical sciences in the United States.

Four specific fueling technologies developed at a federal lab are now licensed to a private fusion company. Those technologies address a genuine gap in pellet production rates and tritium handling, and the deal fits into a broader, ongoing collaboration aimed at bringing stellarator fusion closer to commercial viability.

Kelly Lippke

Kelly is an experienced writer with 15 years of experience exploring the big stories that shape our world, from tech breakthroughs and space exploration to climate, energy, and the fascinating quirks of science. She has a talent for turning complex ideas into sharp, memorable insights that stay with readers long after they’ve finished reading.